Background: Perioperative use of cefazolin has been associated with severe allergic reactions, and patients are usually labelled as allergic to penicillin afterwards. The aim of our study was to describe a group of patients with immediate reactions to cefazolin, with proven selective hypersensitivity reactions. Methods: Systematic review of all patients followed at our drug centre with cefazolin-related reactions, between January 2012 and December 2016. All patients were investigated according to the European Network for Drug Allergy (ENDA) recommendations through skin testing (major and minor penicillin determinants, penicillin, amoxicillin, cefazolin, cefuroxime and ceftriaxone) and oral challenges tests. Results: We included 7 patients (median age 40 years) with perioperative anaphylactic reactions immediately after cefazolin injection, 4 with hypotension and 1 with Kounis syndrome (KS) type I. The presence of a selective IgE-mediated hypersensitivity through positive skin tests to cefazoline has been proven in all patients. Two patients experienced systemic reactions during skin testing. All patients were successfully challenged with amoxicillin, and they tolerated cefuroxime. Conclusions: Cefazolin can be responsible for immediate severe allergic reactions in perioperative setting, including KS. Allergological workup is essential for an accurate diagnosis and to explore cross-reactivity between cefazolin and other beta-lactams. Our experience confirmed that patients with IgE-mediated hypersensitivity reactions to cefazolin can tolerate other beta-lactams. This selective pattern of clinical reactivity may be explained by its particular chemical structure, whose R1 side-chain is different from other beta-lactams.

Keywords:
Anaphylaxis, Drug Allergy, Drug-induced anaphylaxis, Kounis syndrome, Cefazolin, Diagnostic workup, Skin tests, Drug provocation tests
1.
Mertes PM, Volcheck GW, Garvey LH, Takazawa T, Platt PR, Guttormsen AB, -Tacquard C: Epidemiology of perioperative anaphylaxis. Presse Med 2016; 45: 758–767.
2.
Galvão VR, Giavina-Bianchi P, Castells M: Perioperative anaphylaxis. Curr Allergy Asthma Rep 2014; 14: 452.
3.
Berroa F, Lafuente A, Javaloyes G, Cabrera-Freitag P, de la Borbolla JM, Moncada R, Goikoetxea MJ, Sanz ML, Ferrer M, Gastaminza G: The incidence of perioperative hypersensitivity reactions: a single-center, prospective, cohort study. Anesth Analg 2015; 121: 117–123.
4.
Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montanez MI, Fernandez T, Blanca M: Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 2006; 117: 404–410.
5.
Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ: IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. J Allergy Clin Immunol 2010; 126: 994–999.
6.
Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Zaffiro A, Caruso C, Quaratino D: IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol 2015; 136: 685–691.e3.
7.
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA; American Society of Health-System Pharmacists (ASHP); Infectious Diseases Society of America (IDSA); Surgical Infection Society (SIS); Society for Healthcare Epidemiology of America (SHEA): Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14: 73–156.
8.
Uyttebroek AP, Decuyper, II, Bridts CH, Romano A, Hagendorens MM, Ebo DG, Sabato V: Cefazolin hypersensitivity: toward optimized diagnosis. J Allergy Clin Immunol Pract 2016; 4: 1232–1236.
9.
Gonzalez-Estrada A, Pien LC, Zell K, Wang XF, Lang DM: Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States. J Allergy Clin Immunol Pract 2015; 3: 101–105.e1.
10.
Sade K, Holtzer I, Levo Y, Kivity S: The -economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 2003; 33: 501–506.
11.
Shah NS, Ridgway JP, Pettit N, Fahrenbach J, Robicsek A: Documenting penicillin allergy: the impact of inconsistency. PLoS One 2016; 11:e0150514.
12.
Kim MH, Lee JM: Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Allergy Asthma Immunol Res 2014; 6: 485–495.
13.
Pichichero ME, Zagursky R: Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol 2014; 112: 404–412.
14.
Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, -Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, -Terreehorst I, Group EEDAI: Skin test concentrations for systemically administered drugs – an ENDA/EAACI drug allergy interest group position paper. Allergy 2013; 68: 702–712.
15.
Testi S, Severino M, Iorno ML, Capretti S, Ermini G, Macchia D, Campi P: Nonirritating concentration for skin testing with cephalosporins. J Invest Allergol Clin Immunol 2010; 20: 171–172.
16.
Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet PJ, Merk HF, Sanz ML, Ott H, Atanasković-Marković M: Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64: 183–193.
17.
Pipet A, Veyrac G, Wessel F, Jolliet P, Magnan A, Demoly P, Bousquet PJ: A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities. Clin Exp Allergy 2011; 41: 1602–1608.
18.
Mota I, Gaspar A, Benito-Garcia F, Correia M, Chambel M, Morais-Almeida M: Drug-induced anaphylaxis: seven-year single-center survey. Eur Ann Allergy Clin Immunol 2018 (in press).
19.
Kuhlen JL Jr, Camargo CA Jr, Balekian DS, Blumenthal KG, Guyer A, Morris T, Long A, Banerji A: Antibiotics are the most commonly identified cause of perioperative hypersensitivity reactions. J Allergy Clin Immunol Pract 2016; 4: 697–704.
20.
Kounis NG, Zavras GM: Histamine-induced coronary artery spasm: the concept of allergic angina. Br J Clin Pract 1991; 45: 121–128.
21.
Kounis NG: Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med 2016; 54: 1545–1559.
22.
Renda F, Landoni G, Trotta F, Piras D, Finco G, Felicetti P, Pimpinella G, Pani L: Kounis syndrome: an analysis of spontaneous reports from international pharmacovigilance database. Int J Cardiol 2016; 203: 217–220.
23.
Renda F, Marotta E, Landoni G, Belletti A, Cuconato V, Pani L: Kounis syndrome due to antibiotics: a global overview from pharmacovigilance databases. Int J Cardiol 2016; 224: 406–411.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.